Sandy Aronson

Sandy Aronson is a prominent figure in healthcare technology and artificial intelligence, currently serving as the Executive Director of IT and AI Solutions for Mass General Brigham Personalized Medicine and the Senior Director of IT for their Accelerator for Clinical Transformation.12

Professional Background

Aronson's career spans various roles in technology and healthcare:

• He leads teams that develop and deploy technology to improve clinical processes in areas such as clinical genetics, remote health, and decentralized clinical trials.1
• His work focuses on building infrastructure that supports the evolution and practice of genetic-based personalized medicine in both patient-facing and laboratory settings.12
• Aronson's team has developed the GeneInsight Suite of applications, which were registered as a medical device and distributed.1

Current Projects and Research

Aronson is involved in several cutting-edge initiatives:

• Developing and validating Generative AI functionality to support variant assessment in whole genome sequence management and interpretation.1
• Enhancing remote patient management capabilities using Generative AI to improve trial quality and cost-effectiveness in decentralized clinical trials.1
• Investigating the use of Generative AI in clinical trial screening and scientific literature review for genetic variant assessment.34

Education

Aronson holds multiple advanced degrees:

• Masters in Organizational Behavior from Stanford University
• Bachelors in Computer Science from Stanford University
• Masters focused in Biology from Harvard Extension School12

Recent Publications

Aronson has contributed to significant research in the field of AI in healthcare:

• Co-senior author of a study published in NEJM AI examining the use of Generative AI for clinical trial screening.3
• Corresponding author of a paper in NEJM AI investigating the use of Generative AI in scientific literature review for genetic variant assessment.4

Sandy Aronson's LinkedIn username is sandy-aronson-13995, reflecting his professional presence on the platform.